Indirubin Inhibits TRAIL-Induced Activation of Death Receptor 5 in Jurkat Cells
This study has elucidated previously unknown properties of indirubin that make it a promising candidate for therapeutic investigation of diseases in which overactivation of DR5 underlies pathology.PMID:37063699 | PMC:PMC10100512 | DOI:10.1177/1934578x221144580 (Source: Natural Product Communications)
Source: Natural Product Communications - April 17, 2023 Category: Biochemistry Authors: Malaney C Young Nagamani Vunnam Robyn T Rebbeck Samantha L Yuen David D Thomas Jonathan N Sachs Source Type: research